Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge.
‘Pharma Bro’ Martin Shkreli Says ‘Good Chance’ Inmune Bio Stock Will Slip 90% On Monday
Where Today's News Shapes Tomorrow